Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics

There is an urgent need for novel agents to treat drug-resistant bacterial infections, such as multidrug-resistant Staphylococcus aureus (MRSA). Desirable properties for new antibiotics include high potency, narrow species selectivity, low propensity to elicit new resistance phenotypes, and synergy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Fang, Yongliang, Kirsch, Jack R., Li, Liang, Brooks, Seth A., Heim, Spencer, Tan, Cynthia, Eszterhas, Susan, Cheng, Hao D., Zhao, Hongliang, Xiong, Yan Q., Griswold, Karl E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2021
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092544/
https://ncbi.nlm.nih.gov/pubmed/33318001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01707-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados